Accurate, complete, Real-World data for clinical trials that accelerates innovation in new therapies.

The Challenge

Clinical trials are the crucial bottleneck in developing new therapies; weak data makes developing these new therapies very slow, difficult, risky, and costly.

The payoff from accelerating innovation is large and worthwhile:

Therapies reach patients faster

$300k/ day cost saving

$3.0M/ day revenue gain for earlier launch

BY THE NUMBERS

~8 yrs

Avg. length of clinical trials in drug development

$2.3B

Average cost to bring a new drug to market

~$35B

Annual spend by Big Pharma on Phase II and Phase III clinical trials
– of which ~$3.3B in CNS / Brain

30%

of drugs entering Phase II fail to produce sufficiently powerful data

 

“…the FDA prefers content that is more representative of daily life functioning…”

— FDA response letter rejecting wrist-worn Parkinson's clinical trial device proposed by Verily, June 2021

 

“The devices will make it possible to measure important quality of life indicators, including daily activity and sleep quality”

— The Future of Drug Trials Is Better Data and Continuous Monitoring, Harvard Business Review, May 2019

The Challenge

markus-spiske-466ENaLuhLY-unsplash.jpg

Today’s clinical trials produce data that is:

  • Not objective

  • Not precise and accurate

  • Not complete

  • Not real-world evidence

➡

Causing trials to be:

  • Slower

  • Harder

  • Riskier

  • Costlier

Infographic -- Solution 3 -- Web.jpg
 

The Solution

Our solution is better data.

We measure smaller effect sizes, with greater specificity and selectivity, over more representative populations. Our solution generates better data than all competitive alternatives. We make trials faster, easier and less risky.

Our platform integrates very rich data in the home with third party data and conventional clinical examinations.

We deliver more powerful data, continuously and consistently as an end-to-end service.

The Platform

Our state-of-the-art platform delivers decentralized, ambient, accurate, complete, Real-World Data. Our robust and transparent architecture enables the data to be validated and verified. The platform delivers a great user experience and a complete end-to-end turnkey platform.

It combines multiple vision and radar sensors in the home with a hub, a touch screen for interaction and cloud connectivity to deliver the results to the customers in the cloud.

 
Platform-NEW-transparent.png

Insights

  • The Future of Drug Trials Is Better Data and Continuous Monitoring

    Digital technologies are becoming ubiquitous, effective, and cost efficient, but are underutilized in medicine.

    Read More

  • Biggest challenges with decentralised clinical trials: Survey

    The COVID-19 pandemic has triggered several changes in the pharmaceutical sector across the world with several…

    Read More

  • Digital health technologies hold key to new Parkinson's treatments

    Global stakeholders come together to collaborate with urgency to address unmet needs for Parkinson's therapies.

    Read More

About Us

We are the right team, at the right time. WKD.SMRT was founded by a team of professors and CTOs from MIT and Dartmouth. We recognize the potential of smart-home technologies to accelerate clinical trials. With technology and medical expertise, and entrepreneurial experience we are in the right place to innovate. Recent enabling innovation, in particular in vision, sensing and machine learning, now makes this doable.

Let’s Talk

Are you responsible for implementing digital technology to clinical trials in your organization? Have a burning passion to transform how clinical trials are run? Or just wicked smart and curious about what we are making?

Newsletter Sign Up

Stay involved with our latest developments.

Join Our Team

Interested in joining our team of skilled innovative individuals?